MGWM
RMD icon

Marks Group Wealth Management’s ResMed RMD Stock Holding History

Marks Group Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Sell
9,548
-17,694
-65% -$3.67M 0.16% 142
2026
Q1 		$6.12M Sell
27,242
-3,397
-11% -$847K 0.59% 63
2025
Q4 		$7.38M Sell
30,639
-3,659
-11% -$936K 0.71% 46
2025
Q3 		$9.39M Sell
34,298
-1,696
-5% -$463K 0.87% 29
2025
Q2 		$9.29M Sell
35,994
-2,037
-5% -$486K 0.86% 35
2025
Q1 		$8.51M Buy
+38,031
New +$8.88M 0.82% 49

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marks Group Wealth Management's RMD Position: Q2 2026 in Review

Marks Group Wealth Management reduced its ResMed (RMD) stake by 65% in Q2 2026, selling an estimated $3.67M and leaving 9,548 shares worth $1.86M. The position accounts for 0.16% of the portfolio, ranked #142.

Marks Group Wealth Management first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.39M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Marks Group Wealth Management held 9,548 shares of ResMed worth $1.86M as of Q2 2026.
  • Marks Group Wealth Management sold 17,694 ResMed shares in Q2 2026, an estimated $3.67M.
  • ResMed made up 0.16% of Marks Group Wealth Management's portfolio in Q2 2026, its #142 holding.
  • Marks Group Wealth Management first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • Marks Group Wealth Management's ResMed position peaked at $9.39M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Marks Group Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.